Antibiotics vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)
- Antibiotics for the induction and maintenance of remission in ulcerative colitis 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 46 participantsGRADE not reported
Antibiotics showed no clear difference in serious adverse events compared with placebo (low certainty).
Antibiotics showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
It is very uncertain whether antibiotics plus probiotics changes serious adverse events compared with placebo or no intervention (very low certainty).
It is very uncertain whether antibiotics plus probiotics changes withdrawals due to adverse events compared with placebo or no intervention (very low certainty).
Antibiotic with anti‐TNF showed no clear difference in adverse events compared with placebo with anti‐TNF (moderate certainty).
Antibiotic showed no clear difference in adverse events compared with placebo (high certainty).
The review found no eligible studies for this question.
Antibiotic showed no clear difference in serious adverse events compared with placebo (low certainty).
Antibiotic with anti‐TNF showed no clear difference in withdrawal due to adverse events compared with placebo with anti‐TNF (low certainty).
Antibiotic showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).